BEN
48
-4
AMP
69
2
DUK
44
4
BA
44
4
DE
38
5
SNA
56
3
AON
17
-15
ADM
36
2
CAT
68
6
QCOM
73
2
DLTR
42
-2
YUM
68
2
IP
36
6
UNH
42
-13
LOW
56
4
OKE
70
3
PNR
65
3
KIM
58
4
AIZ
71
3
ESS
59
3
BEN
48
-4
AMP
69
2
DUK
44
4
BA
44
4
DE
38
5
SNA
56
3
AON
17
-15
ADM
36
2
CAT
68
6
QCOM
73
2
DLTR
42
-2
YUM
68
2
IP
36
6
UNH
42
-13
LOW
56
4
OKE
70
3
PNR
65
3
KIM
58
4
AIZ
71
3
ESS
59
3
Financhill
Back

Bausch Health Companies Quote, Financials, Valuation and Earnings

He cracked the code to crypto

Now he says a new two-year bull market has begun. And he likes one altcoin above all others.
Sell
50

BHC
Bausch Health Companies

Last Price:
8.88
Seasonality Move:
6.86%

7 Day Trial

ALL ACCESS PASS

$ 7

NOW is the time to get in on this trillion-dollar megatrend

Get it here.

Bausch Health Companies Price Quote

$8.88

Bausch Health Companies Key Stats

Sell
50
Bausch Health Companies (BHC) is a Sell
Day range:
$8.74 - $8.89
52-week range:
$5.57 - $11.46
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.37
P/B ratio:
0%
Volume:
2.7M
Avg. volume:
3.5M
1-year change:
20.49%
Market cap:
$3.3B
Revenue:
$8.8B
EPS:
$-1.62

How Much Does Bausch Health Companies Make?

Is Bausch Health Companies Growing As A Company?

Bausch Health Companies Stock Price Performance

What Is Bausch Health Companies 52-Week High & Low?

Bausch Health Companies Price To Free Cash Flow

Is It Risky To Buy Bausch Health Companies?

Is Bausch Health Companies Cash Flow Positive?

  • What Is BHC Cash Flow From Operations?
    Cash flow from operations (TTM) is $1B
  • What Is Bausch Health Companies’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.5B
  • What Is Bausch Health Companies’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.1B

Bausch Health Companies Return On Invested Capital

  • Is Management Doing A Good Job?
    BHC return on invested capital is -2.76%
  • What Is Bausch Health Companies Return On Assets?
    ROA measures how assets are converting to revenues and is -2.26%
  • What Is BHC Return On Equity?
    ROE is a measure of profitability and is -824.51%

Bausch Health Companies Earnings Date & Stock Price

Bausch Health Companies Competitors

Bausch Health Companies Dividend Yield

Data Unavailable

Bausch Health Companies Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 14.76%
Revenue: 9.8% 4.93%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 6
Sell Recommendations: 0
Price Target: 10.36
Upside from Last Price: 16.63%

Major Shareholders

  • How many BHC shares are owned by institutional investors?
    335.6M BHC shares are owned by institutional investors
  • How many BHC shares are owned by insiders?
    12.4M BHC shares are owned by insiders